50
Views
13
CrossRef citations to date
0
Altmetric
Research Article

Body cavity-based presentation of natural killer cell lymphoma

, &
Pages 293-296 | Published online: 01 Jul 2009

REFERENCES

  • Walts AE, Shintaku IP, Said JW. Diagnosis of malignant lymphomas in effusions from patients with AIDS by gene rearrangement. American Journal of Clinical Pathology 1990;94:170 – 175.
  • Ansari MQ, Dawson DB, Nador R, Rutherford C, Schneider NR, Latimer MJ, Picker L, Knowles DM, McKenna RW. Primary body cavity-based AIDS-related lymphomas. American Journal of Clinical Pathology 1996;105:221 – 229.
  • Green I, Espiritu E, Ladanyi M, Chaponda R, Wieczorek R, Gallo L, Feiner H. Primary lymphomatous effusions in AIDS: a morphological, immunophenotypic, and molecular study. Modern Pathology 1995;8:39 – 45.
  • Cesarman E, Chang Y, Moore PS, Said JW, Knowles DM. Kaposi’s sarcoma-associated herpesvirus-like DNA sequences in AIDS-related body-cavity-based lymphomas. New England Journal of Medicine 1995;332:1186 – 1191.
  • Banks PM, Warnke RA. Primary effusion lymphoma. In: Jaffe ES, Harris NL, Stein H, Vardiman JW, editors. World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues. Lyon: IARC Press; 2001. pp. 179 – 180.
  • Spits H, Lanier LL, Phillips JH. Development of human T and natural killer cells. Blood 1995;85:2654 – 2670.
  • Jaffe ES, Harris NL, Stein H, Vardiman JW, editors. Mature T cell and NK Cell Neoplasms. In: World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues. Lyon: IARC Press; 2001. pp. 179 – 180.
  • Chan JK. Peripheral T-cell and NK-cell neoplasms: an integrated approach to diagnosis. Modern Pathology 1999;12:177 – 199.
  • Kanegane H, Yachie A, Miyawaki T, Tosato G. EBV-NK cell interactions and lymphoproliferative disorders. Leukemia and Lymphoma 1998;29:491 – 498.
  • Dunphy CH. Natural killer cell lymphoma of the small intestine: Diagnosis by flow cytometric immunophenotyping of paracentesis fluid. Diagnostic Cytopathology 1999;20:246 – 248.
  • Martin AR, Chan WC, Perry DA, Greiner TC, Weisenburger DD. Aggressive natural killer cell lymphoma of the small intestine. Modern Pathology 1995;8:467 – 472.
  • Nakamura S, Suchi T, Koshikawa T, Takagi N, Hayashi K, Koike K, Suzuki H, Ogura M, Kurita S, Oyama A. Aggressive rectal lymphoma of large granular lymphocytes with the histologic feature of an angiocentric growth pattern. Cancer 1993;71:249 – 256.
  • Mhawech P, Medeiros LJ, Bueso-Ramos C, Coffey DM, Gei AF, Shahab I. Natural killer-cell lymphoma involving the gynecologic tract. Archives of Pathology and Laboratory Medicine 2000;124:1510 – 1513.
  • Ogata M, Imamura T, Mizunoe S, Ohtsuka E, Kikuchi H, Nasu M. Natural killer cell-type body cavity lymphoma following chronic active Epstein-Barr virus infection. American Journal of Hematology 2003;73:126 – 130.
  • Medeiros LJ, Peiper SC, Elwood L, Yano T, Raffeld M, Jaffe ES. Angiocentric immunoproliferative lesions: a molecular analysis of 8 cases. Human Pathology 1991;22:1150 – 1157.
  • Medeiros LJ, Jaffe ES, Chen Y-Y, Weiss LM. Localization of Epstein-Barr viral genomes in angiocentric immunoproliferative lesions. American Journal of Surgical Pathology 1992; 16:439 – 447.
  • Lei KI, Chow JH, Johnson PJ. Aggressive primary natural killer cell lymphoma of the caecum: a case report and literature review. Clinical Oncology 1997;9:191 – 194.
  • Tanaka M, Suda T, Haze K, Nakamura N, Sato K, Kimura F, Motoyoshi K, Mizuki M, Tagawa S, Ohga S, et al. Fas ligand in human serum. Nature Medicine 1996;2:317 – 322.
  • Sato K, Kimura F, Nakamura Y. An aggressive nasal lymphoma accompanied by high levels of soluble Fas ligand. British Journal of Haematology 1996;94:379 – 382.
  • Galle PR, Hofmann WJ, Walczak H, Schaller H, Otto G, Stremmel W, Krammer PH, Runkel L. Involvement of CD95 (Apo-1/Fas) receptor and ligand in liver damage. Journal of Experimental Medicine 1995;182:1223 – 1230.
  • Liang R, Chen F, Lee CK. Autologous bone marrow transplantation for primary nasal T/NK cell lymphoma. Bone Marrow Transplantation 1996;19:91 – 93.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.